Response to PD1 inhibition in conventional chondrosarcoma

BACKGROUND: Chondrosarcoma is one of the most common malignant bone tumors in adults. Conventional chondrosarcoma represents around 85% of all chondrosarcomas and is notoriously difficult to treat with chemotherapy. CASE PRESENTATION: We describe a 67-year-old man with metastatic conventional chondr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Michael J., Ricciotti, Robert W., Mantilla, Jose, Loggers, Elizabeth T., Pollack, Seth M., Cranmer, Lee D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156853/
https://www.ncbi.nlm.nih.gov/pubmed/30253794
http://dx.doi.org/10.1186/s40425-018-0413-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156853/
https://www.ncbi.nlm.nih.gov/pubmed/30253794
http://dx.doi.org/10.1186/s40425-018-0413-z

Ejemplares similares